Robert J. Ife

Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor

Colin H. Macphee, Kitty Moores, Helen Boyd et al. · Biochemical Journal · 1999 · 335 citations · Full text

Inflammation, Thrombosis, Lipoprotein-associated Phospholipase A2 +15

3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3)

David G. Smith, Marianne Buffet, Ashley Fenwick et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 160 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +9

The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2

Josie A. Blackie, Jackie C. Bloomer, Murray J. B. Brown et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 129 citations · Full text

Lipoprotein-associated Phospholipase A2, Biochemistry, Potent Inhibitor +8

5-Aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)

Jason Witherington, Vincent Bordas, David Haigh et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 107 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +7

Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor

Colin H. Macphee, Kitty Moores, Helen Boyd et al. · Biochemical Journal · 1999 · 102 citations · Full text

Low-density Lipoprotein, Lipid Peroxidation, Oxidative Stress +17